Publication:
Development and validation of liquid chromatography tandem mass spectrometry method for the quantification of manidipine in human plasma

dc.contributor.authorWannisa Thanakosaien_US
dc.contributor.authorThitirat Pamornen_US
dc.contributor.authorWaraphorn Sisanen_US
dc.contributor.authorPiyapat Pongnarinen_US
dc.contributor.authorPinpilai Jutasompakornen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2020-06-02T05:18:41Z
dc.date.available2020-06-02T05:18:41Z
dc.date.issued2020-01-01en_US
dc.description.abstract© 2020 Mahidol University - Faculty of Pharmacy. A sensitive and selective liquid chromatography tandem mass spectrometric (LC-MS/MS) analytical method has been validated to quantify manidipine in human plasma using desipramine as an internal standard (IS). Liquid-liquid extraction (LLE) with a mixture of methyl-t-butyl ether and hexane (4:1, v/v) was used for sample preparation. The separation of analytes and internal standard was performed on a C18 column (3 mm x 50. mm, particle size 2.5 μm) with gradient elution of (A) 0.05% formic acid and (B) acetonitrile. The mass spectrometry method was performed employing positive electrospray ionization (ESI) operating in multiple reaction monitoring (MRM) mode, monitoring the transitions of m/z 610.98 > 166.95 for manidipine and m/z 266.95 > 235.94 for the IS. The total analytical run time was 6 min. The calibration curve was linear over manidipine concentrations ranging from 0.1 ng/mL to 20 ng/mL in plasma with a correlation coefficient (r2) of 0.995 or better. The lower limit of quantification (LLOQ) and limit of detection (LOD) for manidipine were 0.1 ng/mL and 0.0125 ng/mL, respectively. Accuracy and precision were within the acceptance criteria of the United States (US) Food and Drug Administration (FDA) guidelines. The rapid and highly sensitive LC-MS/MS method has been developed and successfully applied to a bioequivalence study of manidipine in Thai healthy volunteers after oral administration.en_US
dc.identifier.citationPharmaceutical Sciences Asia. Vol.47, No.2 (2020), 142-152en_US
dc.identifier.doi10.29090/psa.2020.02.019.0035en_US
dc.identifier.issn25868470en_US
dc.identifier.issn25868195en_US
dc.identifier.other2-s2.0-85085172310en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/56300
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085172310&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleDevelopment and validation of liquid chromatography tandem mass spectrometry method for the quantification of manidipine in human plasmaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085172310&origin=inwarden_US

Files

Collections